Stifel Financial
ARGS

Stifel Financial’s Argos Therapeutics, Inc. ARGS Stock Holding History

Stifel Financial’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,328
Closed -$10K – 2840
2017
Q4 		$10K Buy
3,328
+50
+2% +$168 ﹤0.01% 2641
2017
Q3 		$12K Hold
3,278
– – ﹤0.01% 2567
2017
Q2 		$24K Buy
3,278
+2,250
+219% +$19.2K ﹤0.01% 2528
2017
Q1 		$9K Buy
+1,028
New +$65.1K ﹤0.01% 2522

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Stifel Financial's ARGS Position: Q1 2018 in Review

Stifel Financial sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2018, closing a stake of 3,328 shares — an estimated $10K sold.

Stifel Financial first reported a position in ARGS in Q1 2017 and held it in 4 quarters. The position peaked at $24K in Q2 2017. 16 funds tracked by Wall St. Rank hold ARGS as of Q1 2018.

  • Stifel Financial reported no remaining Argos Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Stifel Financial sold 3,328 Argos Therapeutics, Inc. shares in Q1 2018, an estimated $10K.
  • Stifel Financial first reported a position in Argos Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
  • Stifel Financial's Argos Therapeutics, Inc. position peaked at $24K in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2018.

Based on Stifel Financial's 13F filing for Q1 2018, filed 11 May 2018.